Search results

We identified a novel immuno-oncology target through bacterial metabolites that activate tumor-residing macrophages, triggering a potent anti-tumor response. By leveraging natural metabolic processes, we develop small molecule therapies to enhance the body’s native immune defense against cancer.

We develop animal-based products via cell cultivation, combining proprietary animal cell biology with scalable bioprocessing at favorable unit economics. The platform starts with the world's first cultivated whole-cut beef and expands into functional applications, like cell-derived collagen.

Apricot BIO is a first-time launcher of a Functional Precision Oncology platform performing deep molecular phenotyping of drug responses for personalised therapy recommendations for early to late-stage clinical decision-making leading to more precise, evidenced-based recommendations for doctors.

Athebio develops ultra-stable biotherapeutics using proprietary Athebody® DARPin molecules with high affinity and specificity. We partner on radiotherapeutics, T cell engagers, targeted delivery (LNP/AAV/oligo) and affinity ligands, enabling breakthrough therapeutic strategies.

Baker McKenzie is an international law firm with offices in Geneva and Zurich, offering top-tier legal advice across all areas of business law. Our team of 130 lawyers provides domestic and international clients with innovative solutions across 74 offices in 45 countries.

Betta Scientific is a Life Sciences consultancy. We support start-ups and established companies in entering international markets. Our clients rely on us to design and execute global go-to-market strategies, build international distribution networks, and accelerate revenue generation across borders.

We at Bioengineering AG design and build customized equipment to improve bioproduction efficiency in biotech, novel food, and biopharma plants. Our engineering teams develop reliable bioreactors and fermenters, from lab scale to production, for clients worldwide. Trusted for over 50 years.

Our comprehensive services for early phase drug development, enables you to get your product to market faster. Our state-of-the-art Zürich laboratory focuses on science, compliance and speed to deliver high-quality data analysis. We apply our 40+ years of experience to exceed your expectations.

Cellerys AG is a clinical stage biotechnology company, developing immune tolerance therapeutics for the treatment of multiple sclerosis (MS). Antigenic peptides identified from MS patients are coupled to autologous red blood cells which, when reinfused, restore immune tolerance. in 2021 the company entered a

ClearView helps life science clients build robust strategies. Our work spans asset, franchise, and corporate-level strategy across therapeutic areas, lifecycle stages, and regions of the world.

Caidya is a multi-therapeutic clinical research organization serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, we offer a wide range of clinical services and vast therapeutic expertise.

CMC & More delivers hands-on CMC, regulatory, and quality expertise for biotech and pharma. We bridge discovery to first-in-human trials and beyond with GMP-compliant CMC strategies that derisk development and transform complex products into approval-ready assets.

A Swiss life science company, spin off of UZH developing personalized skin tissue therapy to treat skin defects and beyond.

Delta Medical, based in Zurich, specializes in pharmaceutical marketing, distribution, regulatory affairs, market access, and pharmacovigilance, serving Ukraine and Eurasian markets with tailored commercialization solutions and strategic partnerships.

DiNAQOR has developed a proprietary technology platform and manufacturing capabilities designed to overcome the challenges and limitations of early-stage gene therapy development.

DKSH is a global distribution and strategic solutions partner for life science and industrial specialties. We provide innovative and sustainable pharmaceutical and biopharmaceutical ingredients to manufacturers across Asia, Europe, and North America.

DrM Group (Dr. Mueller AG) designs and manufactures advanced filtration systems, vibratory mixers, and single-use technologies for solid/liquid separation and processing. Headquartered in Switzerland, we serve the biotech, pharmaceutical, chemical, and food industries worldwide.

Enantios is a Swiss startup revolutionizing molecular characterization with in-solution structural analysis of chiral complex molecules and Antibody drug Conjugates (ADCs). Enantios delivers solutions for quality control and drug development in pharmaceutical, biotech, and chemical industries.

At EY, we are proud to be driven by our purpose to build a better working world, helping to create long-term value for our clients, people, and communities. As a trusted partner, we leverage our experience, knowledge, and services around the world.

Eviden is an Atos business that brings together its digital, cloud and big data & security business lines. It will be a global leader in data-driven, trusted and sustainable digital transformation.

EVIIVE develops single extracellular vesicle-based diagnostics to predict immunotherapy response and monitor tumor microenvironment in real time. Our platform integrates advanced flow analytics and machine learning for precision oncology applications.

evitria specializes in CHO-based transient expression of recombinant proteins, with a focus on antibodies—including bispecific, Fc-silenced, and afucosylated formats. With over 100,000 transfections, we are a trusted partner for biotech and pharma worldwide.

EvlaBio is a life science startup dedicated to the development of first-in-class therapeutics in the cardiovascular and cardiorenal space. The lead asset is a Therapeutic Monoclonal Antibody (mAb) targeting unphysiological FGFR4/FGF23 cardiac overdrive in the setting of chronic kidney disease (CKD).

We are a Swiss company promoting innovation and technology using our comprehensive and highly qualified expert knowledge. We offer company assessments and consulting and management to support all actors involved in “turning scientific innovation into successful products on the market”.

Fortrea (formerly Labcorp Drug Development/ Covance) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We provide phase I-IV clinical trial management, clinical pharmacology, technology enabled trial solutions and post-approval services.

Future Health Pharma GmbH represents companies in Switzerland and distributes and markets their products in CH, UK and EU. We act as Marketing Authorisation Holder or establish their affiliate in CH and EU. We also hold an establishment license to handle controlled substances (narcotics) & vaccines.

GlycoEra is developing biologics to selectively degrade autoimmune disease causing circulating proteins rapidly, selectively, and deeply while avoiding broader dampening of the immune system. This offers many potential benefits over existing broad-spectrum immune-suppressing therapies.

GMP4U is offering engineering and consulting services for the life sciences industry. As experts in qualification and validation, we support our clients in ensuring GMP compliance for production equipment, laboratory instruments, and information management systems.

Founded in 2012, headcount is a Swiss recruitment agency specializing in Biotech, Medtech, Pharma, and Digital Health. We combine scientific expertise with recruitment excellence to connect top talent with leading companies, ensuring a perfect cultural and professional fit.

Homburger is a Swiss law firm with more than 150 professionals. Homburger advises and represents enterprises and entrepreneurs in all aspects of commercial law – transactions, proceedings and complex cases, in both a domestic and a global context.

House of Lab Science is the ultimate destination for serviced laboratory space across Switzerland. We believe that lab space should be ready-to-move in, affordable, certified & well equipped. Our lab-as-a-service model is designed to help you advance your research and business from day one.

We plan and execute industrial building projects for the life sciences industry, in which production processes, building services and architecture are optimally coordinated.

ImmunOs Therapeutics AG is a biotechnology company focused on discovering and developing novel human immunomodulatory proteins for cancer with a specific role in innate immunity.

InSphero is the pioneer of industrial-grade, 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology. InSphero supports pharmaceutical and biotechnology researchers in successful decision-making by accurately rebuilding healthy and diseased human physiology in vitro.

InterAx developed a unique drug discovery platform integrating biochemistry, cellular pathways mathematical modelling and AI to decode the cellular communication language. This novel approach enables the rapid and precise identification of differentiated effective and safe candidates.

Jantar is a clinical R&D company in the field of chronic rhinosinusitis. Its product is a nasal spray of dicholine succinate. Clinical efficacy has been demonstrated by well-documented case studies which showed that the drug relieves all symptoms of the disease. A PCT patent has been filed.

Lenz & Staehelin serving global clients from our Geneva, Lausanne and Zurich offices. Our 200+ expert lawyers cover all areas of business law, providing many of the world’s leading companies, organisations and private individuals with insightful, yet always pragmatic and practical, advice.

Life Science Cares Switzerland uses the innovation, financial and human resources of the life science industry to support local charitable projects. Main focus is promoting educational equity by providing young people from socially disadvantaged backgrounds with opportunities in our industry.

LimmaTech Biologics AG is a Swiss clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to protect from the increasing threat of global microbial infections due to emerging antimicrobial resistance (AMR) and sexually transmitted diseases.

LubioScience is the biggest lifescience reagents & services platform in Switzerland. Representing some of the world’s most recognized brands, we provide over 5 million products from more than 120 suppliers and pride ourselves in working with most Swiss biotech companies & start-ups.

Whatever your level of maturity regarding the valorization of data in your company, our Luciders are your trusted advisors to design and implement a data roadmap. We will work closely with your different business units to explore how data, advanced analytics, AI and ML can solve complex challenges.

Mabylon is a clinical-stage company leading innovation in human-derived antibody therapeutics for severe allergies, inflammation, and neurological disorders. MY006, our first-in-class multi-specific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.

MD Bioproducts, with over 30 years of experience, is a worldwide manufacturer and supplier of high-quality antibodies, reagents, peptides, assays, and disease-induction reagents supporting research in arthritis, autoimmune diseases, immunology, inflammation, neurology, metabolism, and oncology.

MedScienceSwiss AG is developing the technology of the future for the treatment of resistant bacteria and has the potential to significantly reduce the number of deaths in hospitals due to nosocomial infections and save resources and money, payers & Nat. Health services. Visit our poster Nr 25 at the Swis

Memo Therapeutics AG develops therapeutic antibodies for viral infections and cancer. Lead asset potravitug targets BKV in kidney transplant recipients; Phase II SAFE KIDNEY data, presented in Nov 2025, support a planned Phase III start in 2026. MTx is also building an oncology discovery pipeline.

MetrioPharm AG, a clinical stage biopharmaceutical development company based in Zurich with a subsidiary in Berlin, Germany, has developed a platform of small molecule drug candidates (oral and i.v.) which targets the modulation of immune cell metabolism without suppressing the immune system.

Miltenyi Biotec Swiss AG is the local subsidiary of Miltenyi Biotec BV&Co KG (Germany). Miltenyi Biotec plays an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy.

MUVON is a Swiss, clinical stage biotech company with the goal of revolutionizing the treatment of diseases caused by muscle damage or degradation through the use of the patients' own cells. Our initial area of focus is the treatment of stress urinary incontinence in women (PhII completed)

At Navignostics we characterize tumors using spatial single-cell proteomics. We use unique capabilities to identify a cancer treatment that will optimally fight a tumor. We accelerate cancer drug development by providing key insights into drug mechanisms and tumor features to pharma companies.

There is a new kit on the block. Swiss start-up NEMIS Technologies AG specialises in the development of simple, safe, and on-site pathogen testing solutions. Its detection test for Listeria monocytogenes is already commercially available in Switzerland, France, and Spain.

The Future Rewritten: Unlocking Genome Editing. By fusing directed evolution, high-throughput characterization, and AI, Nerai creates novel CRISPR editors, more precise and more powerful, making gene editing safer and accessible to more patients.

NexMR offers the first technological solutions to do drug discovery on a benchtop NMR spectrometer without compromising speed and data quality.

The Nikon Microscope Solutions unit is focused on serving customers in research, biotech/pharma, the clinical laboratory, and academia with industry leading microscope-based imaging solutions. In addtion the Nikon BioImaging Lab, is a CRO that provides microscope-based imaging and analysis services.

NovaGo Therapeutics focuses on two regeneration promoting therapeutics aimed at restoring nerve fibre connections in acute spinal cord injury(SCI) and retinal vasculature in diabetic retinopathy(DR), Ph1b clinical trial for SCI was started in Dec 2024. Ph1b studies in DR are planned for end 2025.

We specialize in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. With our proprietary MATCH technology platform, we are fueling a new wave of multi-specific drug candidates engineered with versatility and developability in mind.

ONtrack Biomedical AG is a Swiss spin-off of the University Zurich and University Hospital Zurich which develops in-vitro diagnostic tests for the early and non-invasive detection and monitoring of cancer. Our first product is a urine test for the early detection and monitoring of prostate cancer.

Our goal is to deliver innovations in health care through cutting-edge tech and research, addressing challenges in antimicrobial therapies to improve patient outcomes. We are committed to delivering superior treatments that promote healing and improve quality of life globally.

Procavea Biotech is an ETH Spin-off company developing an innovative protein-based RNA delivery platform. Our focus is to generate siRNA therapeutics in extrahepatic disease areas that are currently unreachable.

As Swiss branch of Promega Corp, Promega AG offers local scientific expertise for 4000+ products covering genomics, proteomics and cell analysis. Promega is a global leader in providing innovative solutions for drug discovery, basic research, human identification, diagnostics and food/water testing.

Real Chemistry is a global healthcare communications network accelerating the journey from molecule to market. We integrate deep scientific and medical expertise, advanced AI, data-driven strategy, and creative excellence to deliver evidence-based engagement and measurable commercial impact.

Tepthera is a spin off from the ETH Zurich focusing on product development in the field of cancer immunotherapy, autoimmune- and infectious diseases.

Santersus AG is an innovative Therapeutic Apheresis company focused on using our patented technology for the cleansing of patient blood of cell free DNA and neutrophil extracellular traps (NETs) looking to revolutionize how we can control the human immune and inflammatory response to disease.

Sartorius is a leading international partner of life sciences research and the biopharmaceutical industry. The Bioprocess Solutions Devision, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidl

Securecell is an innovator for both the biotech and medtech space. Developing use-case applications for automated bioprocessing and smart pharmacoligical facilities, as well as the transformative applications of digital technologies to help hospitals and life scientists solve next-world problems.

Somagenetix is a spin-off from the University of Zurich leveraging scientific, clinical & commercial expertise to solve unmet medical needs. With our gene therapy platform, we aim at becoming a leading company with first & best-in-class treatments for phagocyte-related disorders.

We are specialists for laboratory consumables and pipette service – with a focus on liquid handling. We combine our expertise with a consultative approach so that we can fully understand the daily work of scientists and researchers in order to provide any support needed.

The grow Foundation provides small and large Life Sciences companies ready-to-use laboratories, offices, piloting and production facilities in Wädenswil/Horgen, in size ranging from a few working benches to several thousand m2.

Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members, the association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources.

Swiss Consultant-Network GmbH is developing a new data management system that can be used as a framework for the integration of heterogeneous data in the field of biological research and development. We offer our customers IT engineers, who have in-depth knowledge of computer science disciplines.

Switzerland Global Enterprise (S-GE) links companies, experts and public organisations globally, thus facilitating efficient promotion of foreign trade. Apart from export promotion, S-GE is responsible for promoting Switzerland as a business location abroad.

SYDRA AG (Zurich) is a longevity biotech using a phenotype-first, AI-assisted “Hit-to-Target” early drug discovery platform. We discover small molecules (geroprotectors), validate in vivo (worms – aged mice), then map MoA to build partner-ready drug assets; plus science-backed supplements.

Synple Chem was founded to develop new easy to use automated laboratory equipment for chemistry research labs.

Tandem Therapeutics (Spin-off ETH Zurich & PSI) is tackling the growing unmet medical need in treating fibrosis with precision extracellular matrix targeting. Our novel peptide drug conjugates selectively target mechanical changes in the fibrotic extracellular matrix to potentially halt progression.

therainnova AG provides strategic and operational regulatory affairs consulting for the biopharmaceutical industry in Europe. With expert leadership and a strong partner network, we offer end-to-end regulatory support, including due diligence, to maximize portfolio value.

Topadur Pharma AG, founded in 2015 in Schlieren, is a clinical-stage biopharmaceutical company. Leveraging its proprietary DualTOP™ platform, Topadur develops dual-acting molecules that restore cGMP levels, repairing microcirculation, promoting tissue regeneration, and addressing oxygen deficiency.

TransHeps specializes in iDILI causality assessments, supporting drug developers in clinical trials and managing drug-induced liver injuries. Leveraging cutting-edge expertise, we provide reliable solutions to improve drug safety and accelerate pharmaceutical innovations.

Ultimate Medicine is a Swiss preclinical biotech focused on preserving independence and quality of life for patients with Alzheimer's disease and other dementias.

VACCENTIS AG is a Zurich-based investment company focused on the biotech and pharmaceutical sector. The entire research, production and sales activities are carried out by two highly specialized subsidiaries, VCC MEDICAL and FBM- Pharma, which focus on special methods of personalized medicine

Venture Valuation specializes in independent assessments and valuations of companies/products in biotech/life sciences and runs the business development database Biotechgate with global licensing deals and opportunities www.biotechgate.com and Biotechgate Digital Partnering www.digitalpartnering.com

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.

A dynamic presence in the market – with around 240 legal experts and six locations in all language regions, Walder Wyss is one of the most successful law firms in Switzerland. Continuous growth, dedication and proximity to our clients determine our success.

Watson-Marlow is a specialist manufacturer of pumps and tubing, fluid path components and single-use technology for GMP regulated industries. A portfolio of products and assembly design capabilities allows WMFTS to provid accuracy, reliability, and sterility in all fluid handling applications.

WittKieffer is a top 10 executive search and leadership advisory firm exclusively specialised in life sciences organizations operating at the intersection of academia, science, and healthcare.

Wyss Zurich is a joint accelerator of ETH & University of Zurich. Our mission is to drive the clinical translation of outstanding scientific discoveries into new therapies for patients and innovations in the fields of regenerative medicine and robotics, and hybrid technologies in these fields.

Xlife Sciences is a publicly listed life sciences incubator and accelerator. Xlife is focused on the value development and commercialization of promising research projects from universities and other research institutions. The goal is to bridge research and development to healthcare markets.